Core Viewpoint - The internal conflict within Sinovac Biotech (SVA.NASDAQ) primarily stems from a power struggle between its founders, Pan Aihua (and ally Li Jiaqiang) and Yin Weidong, centered around profit distribution [1][2][15]. Group 1: Internal Conflict and Resolution - After years of internal strife, Sinovac Biotech temporarily resolved the conflict with a substantial dividend payout [3][16]. - In July 2025, the company announced a $7 billion dividend, which significantly alleviated tensions among shareholders [4][17]. - Following the dividend, shareholders experienced substantial financial gains, leading to a reduction in conflicts among them [5][18]. Group 2: Legal Proceedings - On December 29, 2025, a second trial resulted in reduced sentences for Pan Aihua, Luo Deshun, and Li Pengfei, who were previously convicted due to internal disputes [6][19]. - In November 2022, the three were taken into custody by the Zibo Public Security Bureau and later prosecuted for alleged crimes [19]. - The first trial in February 2024 found Pan Aihua guilty of embezzlement and misappropriation of funds, sentencing him to 13 years, while Luo Deshun received 7 years and Li Pengfei 8 years [6][19]. - The second trial significantly reduced their sentences: Pan Aihua's term was shortened to 5 years, Luo Deshun's to 3 years, and Li Pengfei's to 2 years and 9 months [19]. Group 3: Criminal Charges - Pan Aihua and Luo Deshun were charged with misappropriation of funds, a straightforward charge [21]. - Li Pengfei faced more complex charges, including forgery of official documents and company seals [22][23]. - Reports indicated that Li Pengfei forged 49 police seals to create false death certificates and household registration cancellation documents for clinical trial purposes [11][25].
科兴生物百亿美元分红小花絮：有关联方高管买了49个假章伪造死亡证明被判刑